India's pharma industry an asset to the world, says Prime Minister Modi

10 July 2020

Even as Indian pharmaceutical companies are active in international efforts for the development and production of a vaccine for COVID-19, India's Prime Minister Narendra Modi has said the domestic drug industry is an 'asset' not just for its own country but also for the entire world as it leads to reducing the cost of medicine for developing countries.

Highlighting how vaccines developed in India cater to the masses, Mr Modi said vaccines made in India are responsible for two-third of the vaccine needs of the world's children.

The Prime Minister was speaking at the India Global Week 2020 - a three-day virtual conference organized in the UK with 5,000 global participants from 30 nations.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK